Synaptogenix Inc (SNPX)

[Cyosol]

Here's another interesting fact:

While companies such as Celgene and Pfizer have an institutional ownership of over 70%, Neurotrope only has an institutional ownership of 12.01% (https://www.nasdaq.com/symbol/ntrp/institutional-holdings).

As the stock price increases, institutions will have to buy more NTRP shares for their index funds, which should move the price up even further, kind of like a snowball effect.

I think once the market cap of this company reaches $300 million or so, we will see lots of institutions start buying more shares for their small-cap funds, which considering the low float of this stock could lead to rather dramatic price swings.